Brief: Advicenne Announces Reimbursement Of Sibnayal For Treatment Of dRTA In Spain
20/07/2026 17:34
BRIEF-Advicenne Announces Reimbursement Of Sibnayal For Treatment Of dRTA In Spain July 20 (Reuters) - Advicenne SA ALDVI.PA:
ADVICENNE ANNOUNCES THE REIMBURSEMENT OF SIBNAYAL® FOR THE TREATMENT OF DRTA IN SPAIN
ADVICENNE - SIBNAYAL REIMBURSED IN SPAIN AT €409.84 FOR 24 MEQ AND €136.62 FOR 8 MEQ
Source text: ID:nBw3drQh8a
Further company coverage: ALDVI.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Advicenne SA
See all newsCorrected: France's Advicenne swings to H1 net profit as revenue rises
Brief: Advicenne H1 Net Income EUR 4.6 Million
Brief: Advicenne Announces Reimbursement Of Sibnayal For Treatment Of dRTA In Spain
Brief: Advicenne Secures Cash Runway To Q2 2027 Through Bond Financing Of Amount Of Up To €3.8 Mln
Corrected: BRIEF-Advicenne FY Net Income EUR -9.532 Million (March 26)